Recently, Neuralink shared a video in which co-founder DJ Seo showcased the company's latest advancements. In the clip, it was revealed that the next-generation surgical robot has dramatically improved its efficiency, reducing the time needed to implant a single electrode lead from 17 seconds to a mere 1.5 seconds. This robot boasts a compatibility rate that encompasses up to 99% of the population, and its insertion speed is over ten times faster than that of its predecessors. Presently, dozens of test subjects are utilizing the device for 8 hours daily, and a staggering number of over 10,000 patients are eagerly awaiting their turn. Neuralink is also in the process of developing a novel implantation needle capable of penetrating more than 50mm beneath the brain's surface, while simultaneously reducing the cost of the needle holder by a remarkable 95%. Brain-computer interface technology is not limited to enabling mental control over a mouse or computer; it also facilitates the operation of robotic arms. Neuralink is steadily progressing towards a scalable application model. Among its "secret weapons" are surgical robots, implantation devices, and neural decoding technology. The company has set a long-term ambition to complete surgeries within an hour, even with the patient awake. Currently, the number of implantation channels stands at around 1,000, but Neuralink is actively developing devices boasting tens of thousands of channels. In 2024, Neuralink achieved a milestone by implanting its first brain chip into a human. Its inaugural product, 'Telepathy,' promises to empower specific patients to control digital devices through mere thought. However, the widespread acceptance and implementation of brain-computer interface technology still face hurdles in terms of engineering challenges and regulatory approvals.